A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Liva Nova PLC stock. As of the latest transaction made, Citadel Advisors LLC holds 35,200 shares of LIVN stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,200
Previous 59,500 40.84%
Holding current value
$1.65 Million
Previous $3.26 Million 43.33%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$43.38 - $54.59 $39.6 Million - $49.8 Million
-912,849 Reduced 58.34%
651,756 $34.2 Million
Q2 2024

Aug 14, 2024

BUY
$51.76 - $64.15 $5.85 Million - $7.25 Million
113,081 Added 7.79%
1,564,605 $85.8 Million
Q1 2024

May 15, 2024

BUY
$48.6 - $57.12 $14.6 Million - $17.2 Million
300,411 Added 26.1%
1,451,524 $81.2 Million
Q4 2023

Feb 14, 2024

BUY
$43.45 - $53.66 $21 Million - $25.9 Million
482,593 Added 72.19%
1,151,113 $59.6 Million
Q3 2023

Nov 14, 2023

BUY
$50.12 - $58.87 $22.3 Million - $26.1 Million
444,165 Added 197.97%
668,520 $35.4 Million
Q2 2023

Aug 14, 2023

SELL
$42.28 - $51.43 $11.5 Million - $14 Million
-272,196 Reduced 54.82%
224,355 $11.5 Million
Q1 2023

May 15, 2023

BUY
$40.84 - $58.14 $12.1 Million - $17.2 Million
296,207 Added 147.85%
496,551 $21.6 Million
Q4 2022

Feb 14, 2023

BUY
$43.88 - $56.16 $2.54 Million - $3.25 Million
57,901 Added 40.65%
200,344 $11.1 Million
Q3 2022

Nov 14, 2022

BUY
$48.37 - $66.5 $5.04 Million - $6.93 Million
104,197 Added 272.44%
142,443 $7.23 Million
Q2 2022

Aug 15, 2022

SELL
$57.25 - $86.63 $9.98 Million - $15.1 Million
-174,266 Reduced 82.0%
38,246 $2.39 Million
Q1 2022

May 16, 2022

BUY
$71.02 - $86.99 $12.6 Million - $15.4 Million
177,545 Added 507.75%
212,512 $17.4 Million
Q4 2021

Feb 14, 2022

SELL
$76.72 - $92.68 $6.06 Million - $7.32 Million
-79,021 Reduced 69.32%
34,967 $3.06 Million
Q3 2021

Nov 15, 2021

BUY
$76.02 - $88.62 $6.12 Million - $7.14 Million
80,568 Added 241.08%
113,988 $9.03 Million
Q2 2021

Aug 16, 2021

SELL
$73.44 - $87.01 $327,762 - $388,325
-4,463 Reduced 11.78%
33,420 $2.81 Million
Q1 2021

May 17, 2021

SELL
$62.9 - $82.41 $4.62 Million - $6.05 Million
-73,452 Reduced 65.97%
37,883 $2.79 Million
Q4 2020

Feb 16, 2021

SELL
$46.01 - $68.74 $9.09 Million - $13.6 Million
-197,517 Reduced 63.95%
111,335 $7.37 Million
Q3 2020

Nov 16, 2020

SELL
$41.91 - $57.81 $11.3 Million - $15.6 Million
-269,723 Reduced 46.62%
308,852 $14 Million
Q2 2020

Aug 14, 2020

SELL
$39.87 - $56.9 $10.9 Million - $15.5 Million
-272,692 Reduced 32.03%
578,575 $27.8 Million
Q1 2020

May 15, 2020

BUY
$34.22 - $76.49 $26.8 Million - $59.8 Million
781,721 Added 1124.03%
851,267 $38.5 Million
Q4 2019

Feb 14, 2020

SELL
$68.92 - $85.27 $28.3 Million - $35.1 Million
-411,239 Reduced 85.53%
69,546 $5.25 Million
Q3 2019

Nov 14, 2019

SELL
$71.74 - $86.35 $6.45 Million - $7.76 Million
-89,875 Reduced 15.75%
480,785 $35.5 Million
Q2 2019

Aug 14, 2019

BUY
$66.45 - $97.36 $33.8 Million - $49.5 Million
508,840 Added 823.1%
570,660 $41.1 Million
Q1 2019

May 15, 2019

BUY
$86.15 - $100.49 $4.8 Million - $5.6 Million
55,713 Added 912.28%
61,820 $0
Q4 2018

Feb 14, 2019

SELL
$84.14 - $125.42 $8.24 Million - $12.3 Million
-97,979 Reduced 94.13%
6,107 $558,000
Q3 2018

Nov 13, 2018

BUY
$101.02 - $130.95 $1.77 Million - $2.29 Million
17,503 Added 20.22%
104,086 $0
Q2 2018

Aug 10, 2018

SELL
$81.75 - $105.37 $258,411 - $333,074
-3,161 Reduced 3.52%
86,583 $0
Q1 2018

May 11, 2018

SELL
$79.95 - $89.74 $3.84 Million - $4.31 Million
-48,016 Reduced 34.85%
89,744 $7.94 Million
Q4 2017

Feb 09, 2018

BUY
$71.8 - $88.21 $3.02 Million - $3.71 Million
42,081 Added 43.98%
137,760 $11 Million
Q3 2017

Nov 09, 2017

BUY
$60.32 - $70.06 $5.77 Million - $6.7 Million
95,679
95,679 $6.7 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.5B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.